View Information Collection Request (ICR) Package

Please note that the OMB number and expiration date may not have been determined when this Information Collection Request and associated Information Collection forms were submitted to OMB. The approved OMB number and expiration date may be found by clicking on the Notice of Action link below.

View ICR - OIRA Conclusion

OMB Control No: 0920-1186	ICR Reference No: 202402-0920-003
Status: Active	Previous ICR Reference No: 202203-0920-003
Agency/Subagency: HHS/CDC	Agency Tracking No: 0920-1186
Title: [NCEZID] Information Collection for Tuberculosis Data from Referring Entities to CureTB
Type of Information Collection: Revision of a currently approved collection	Common Form ICR: No
Type of Review Request: Regular
OIRA Conclusion Action: Approved with change	Conclusion Date: 05/23/2024
Retrieve Notice of Action (NOA)	Date Received in OIRA: 02/22/2024
Terms of Clearance: Approval is consistent with the understanding that CDC through CureTB will work with entities to ensure that individuals for whom data is being collected (individuals being treated for tuberculosis moving outside of the US) are informed and notified consistent with §1320.8(b)(3) and also notified of any privacy and confidentiality protections.

	Inventory as of this Action	Requested	Previously Approved
Expiration Date	05/31/2027	36 Months From Approved	05/31/2024
Responses	4,050	0	3,914
Time Burden (Hours)	1,139	0	1,103
Cost Burden (Dollars)	0	0	31,105

ICR Summary of Burden

	Total Approved	Previously Approved	Change Due to Agency Discretion
Annual Number of Responses	4,050	3,914	136
Annual Time Burden (Hours)	1,139	1,103	36
Annual Cost Burden (Dollars)	0	31,105	-31,105

Burden increases because of Program Change due to Agency Discretion: Yes

Burden Increase Due to: Changing Regulations

Burden decreases because of Program Change due to Agency Discretion: No

Burden Reduction Due to:

Short Statement: Assurance of treatment completion is an important public health strategy for TB. CDC CureTB provides up-to-date, accurate information between providers, as well as assisting patients to continue treatment as they transit between countries. One of CDC CureTB’s key services is bridging the language divide that otherwise limits the ability of providers in different countries to communicate. Services are offered in all languages for patients and downstream providers. CDC CureTB has also been successful because of its strong partnerships with receiving countries, which streamlines the provision and receipt of information; critical in maintaining seamless continuity of care. The information collected by CDC CureTB provides documentation for successful patient follow-up and allows assessment of strategies for improving outcomes. This information is not reported in other systems, thereby preventing CDC from evaluating TB treatment completion outcomes in globally mobile populations and monitoring program effectiveness. CureTB is updating the number of respondents and total burden hours. There are no changes to instruments.

Annual Cost to Federal Government: $566,180

Does this IC contain surveys, censuses, or employ statistical methods? Yes Part B of Supporting Statement

Does this ICR request any personally identifiable information (see OMB Circular No. A-130 for an explanation of this term)? Please consult with your agency's privacy program when making this determination. Yes

Does this ICR include a form that requires a Privacy Act Statement (see 5 U.S.C. §552a(e)(3))? Please consult with your agency's privacy program when making this determination. No

Is this ICR related to the Affordable Care Act [Pub. L. 111-148 & 111-152]? No

Is this ICR related to the Dodd-Frank Wall Street Reform and Consumer Protection Act, [Pub. L. 111-203]? No

Is this ICR related to the American Recovery and Reinvestment Act of 2009 (ARRA)? No

Is this ICR related to the Pandemic Response? No

Agency Contact: Thelma Sims 4046394771